|
| | Apheresis applications committee of ASFA |
| | 2007 | 2010 |
| | TA modality | Category | Category | Recommendations grade |
|
| FH, homozygous | Selective removal methods TPE | I | I II | 1A 1C |
| FH, heterozygous LDL > 300 mg/dL | Selective removal methods TPE | II | II | 1A 1C |
| FH heterozygous with CDH | Selective removal methods TPE | II | II | — — |
| FH during pregnancy | Selective removal methods TPE | II | II | — — |
| CHD and elevated Lp(a) > 60 mg/dL | — | — | — | — |
| Hypertriglyceridemic pancreatitis (chylomicronemic syndrome) | TPE | III | III | 2C |
|